Enhancing Rheumatology eviCore Integration for Advanced Imaging

Klivira streamlines the complex landscape of prior authorizations, offering robust rheumatology eviCore integration to simplify advanced imaging approvals.

Rheumatology practices face a dual challenge: managing high-cost biologic PAs and navigating benefit managers like eviCore for diagnostic imaging. Efficiently integrating these workflows is crucial for maintaining patient access to critical care and optimizing revenue cycle operations. Klivira provides a clear path to automate and accelerate these processes.

Navigating Rheumatology Advanced Imaging with eviCore

Rheumatology care often relies on advanced diagnostic imaging, such as MRIs for inflammatory arthritis assessment and DEXA scans for osteoporosis management. While eviCore primarily manages radiology benefits, ensuring seamless prior authorization for these specific rheumatology-related imaging services is vital. Klivira's platform is designed to bridge this gap, automating the submission and tracking of imaging PAs.

Common Rheumatology Imaging Triggers for eviCore Prior Authorization

MRI for inflammatory arthritis assessment
Ultrasound-guided joint injections (when requiring prior authorization)
DEXA scans for osteoporosis management in chronic-steroid patients
Other advanced diagnostic imaging as per payer policy

Optimizing eviCore Integration for Rheumatology Workflows

Integrating with eviCore for radiology benefit management requires precise documentation and adherence to specific clinical criteria. Klivira facilitates this by automating data extraction from EMRs and populating eviCore's required fields, reducing manual errors and accelerating submission times. This ensures that essential imaging studies for rheumatology patients are approved efficiently.

Critical Documentation for Rheumatology Imaging Prior Authorizations

Accurate ICD-10 diagnosis documentation relevant to the imaging request
Clinical notes supporting the medical necessity of the advanced imaging
Previous imaging reports or conservative care documentation, if required by payer policy
Relevant disease activity assessments (e.g., DAS28, CDAI) if supporting inflammatory disease imaging

Klivira's Holistic Approach to Rheumatology Prior Authorization

Beyond eviCore imaging integration, Klivira offers a comprehensive platform for the high-volume prior authorizations characteristic of rheumatology. This includes managing complex biologic and targeted therapy PAs, addressing step therapy requirements, and handling periodic re-authorizations for chronic treatments, all within a unified system.

Klivira's Core Capabilities for Rheumatology Prior Authorization

ACR-guideline-aware policy logic for step therapy sequencing
Biosimilar substitution routing tailored to per-payer mandates
Periodic re-authorization workflows for chronic biologic treatments
Medical-vs-pharmacy benefit split routing for various agents
Integration with EMRs via SMART on FHIR for automated data retrieval

Frequently asked questions

How does Klivira handle the specific documentation required for rheumatology imaging PAs through eviCore?

Klivira automates the extraction of relevant clinical data, such as ICD-10 codes and supporting clinical notes, directly from your EMR. This ensures that all necessary information for eviCore's imaging review criteria is accurately captured and submitted, minimizing manual data entry and potential delays.

Can Klivira integrate with our existing EMR to streamline eviCore submissions for rheumatology?

Yes, Klivira integrates seamlessly with major EMR systems using industry standards like SMART on FHIR. This enables automated data flow for prior authorization requests, including those for eviCore-managed imaging services, reducing administrative burden for your staff.

Does Klivira differentiate between imaging PAs and drug PAs in rheumatology?

Klivira's platform is designed to manage diverse prior authorization types. While it automates eviCore submissions for imaging, it also handles the complexities of biologic and targeted therapy PAs, including step therapy and biosimilar mandates, providing a unified solution for all rheumatology PA needs.

How does Klivira address ongoing re-authorization for chronic rheumatology treatments?

Klivira includes a dedicated workflow for periodic re-authorizations, common for chronic biologic treatments. The system tracks re-authorization due dates and prompts for necessary continuous response documentation, ensuring timely submissions and uninterrupted patient care.

What kind of support does Klivira offer for new or evolving eviCore policies related to rheumatology?

Klivira continuously monitors and updates its platform to reflect evolving payer policies, including those from eviCore. Our system's policy logic is regularly reviewed to ensure compliance with the latest clinical guidelines and benefit management requirements, minimizing denials due to outdated information.